the cancer drugs fund for england has cut 19 life - extending treatments it claims are too expensive after a review in january thousands of cancer sufferers will lose out on â last chance â drugs after the nhs withdrew approval for their use
the cancer drugs fund for england has cut 19 life - extending treatments it claims are too expensive after a review in january
new patients needing these drugs will no longer be able to get them on the nhs without a consultant âs special request
but experts say this is doomed to fail and they will effectively only be available privately often costing thousands of pounds
following appeals , four drugs will be reconsidered and remain available in the meantime
â the Â£ 280million - a - year cancer drugs fund ( cdf ) which began in april 2011 has led to around 55,000 patients in england getting drugs banned on the nhs by nice , the rationing body , or awaiting approval
â he needs to justify why he no longer believes doctors should be able to prescribe the drugs they think will benefit their patients
â from yesterday , any patients who faces an unfortunate diagnosis of advanced cancer will no longer be able to benefit from the treatments that have been removed from the cancer drugs fund
â new patients needing these drugs will need a consultant âs special request to access the drugs on the nhs dr rob glynne-jones , chief medical advisor of bowel cancer uk , said zaltrap was an effective anticancer drug , which can improve the chances of long - term survival
he said â i am shocked that men in england can not get the same drugs as men in other european countries , especially when we have a cancer drugs fund to supposedly pay for them
â tarja stenvall , general manager for sanofi in the uk , said the company was continuing a â dialogue â with england to explore immediate ways of maintaining access to patients for jevtana
a spokesman for england said â nhs cancer doctors on the cancer drugs fund panel have taken a careful look at how we ensure he drugs available offer the best clinical benefit , getting the most for patients from every pound